Quantitative open-access HPLC analysis: a new calibration approach

Article

Pharmaceutical Technology Europe

Pharmaceutical Technology EuropePharmaceutical Technology Europe-10-01-2010
Volume 22
Issue 10

A novel tool enables users to generate reliable data for yields in solution and for assays of isolated solids using high?performance liquid chromatography without having to prepare standards.

A novel tool enables users to generate reliable data for yields in solution and for assays of isolated solids using high‑performance liquid chromatography without having to prepare standards. The authors discuss the approach taken to develop the tool, its associated protocols and how it can be used to calculate data.

Read the full article here

Articles in this issue
Validating Single-Use Systems
Validating Single-Use Systems
EGA Position On The EC's Proposal For A Falisifed Medicines Directive
i1-687924-1408624996803.jpg
Green is the word
Using Certified Reference Material to Produce Compliant Water Purity Data
Using Certified Reference Material to Produce Compliant Water Purity Data
i2-687920-1408625003549.gif
News
The Pros And Cons Of Single-Use Systems
i2-687918-1408625010027.gif
Europe: A Future Leader in Vaccines?
Developing A Quality Agreement Template For Single-Use Systems
Developing A Quality Agreement Template For Single-Use Systems
Online Monitoring Of Continuous Hot Melt Extrusion
Online Monitoring Of Continuous Hot Melt Extrusion
An All-Round Excipient For Direct Compression
An All-Round Excipient For Direct Compression
Quantitative open-access HPLC analysis: a new calibration approach
i1-182996-1408680981782.jpg
Braille packaging & European generics growth
Recent Videos
A CDMO’s Role in API Quality
A CDMO’s Role in API Quality
Ask the Expert: Quality Control Units
Ask the Expert: Quality Control Units
Industry Outlook 2025: European Geopolitical Impact on Pharma
Industry Outlook 2025: European Geopolitical Impact on Pharma
Industry Outlook 2025: Political Implications for Pharma
Industry Outlook 2025: Political Implications for Pharma
Ask the Expert: EU Data Protection
Ask the Expert: EU Data Protection
Industry Outlook 2025: The Impact of Politics on Pharma
Industry Outlook 2025: The Impact of Politics on Pharma
Industry Outlook 2025: Technology as a Supporting Element
Industry Outlook 2025: Technology as a Supporting Element
Industry Outlook 2025: Talent Up for Grabs
Industry Outlook 2025: Talent Up for Grabs
INTERPHEX 2025: ‘Breaking Up the Octopus’ of Single-Use Systems
INTERPHEX 2025: ‘Breaking Up the Octopus’ of Single-Use Systems
INTERPHEX 2025: Advanced Flow Sensor Technologies Enable More Accurate Measurement
INTERPHEX 2025: Advanced Flow Sensor Technologies Enable More Accurate Measurement
Related Content
A magnifying glass examining a vintage vaccine vial surrounded by four minimalistic chart icons, symbolizing healthcare, medicine, and analytics in the context of global health monitoring. | Image source: ©huiying - stock.adobe.com

ICH Q6B for Analytics

Richard Easton;Christopher Ziegenfuss
June 6th 2025
Article

ICH Q6B provides expectations and a clear framework for the structural characterization of biopharmaceutical products.

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Felicity Thomas
June 25th 2024
Podcast

In this episode, Hanns-Christian Mahler from ten23 Health chats about the advances in fill/finish.

Landkarte *** Europa | Image credit: ©beugdesign - Stock.adobe.com

EMA Is Tackling Vulnerabilities in the Supply Chain of Radiopharmaceuticals

Cheryl Barton
June 4th 2025
Article

EMA has published recommendations to address potential radiopharmaceutical shortages.

Drug Solutions Podcast: All About Data: Looking at the EHDS in More Detail

Drug Solutions Podcast: All About Data: Looking at the EHDS in More Detail

Felicity Thomas
May 28th 2024
Podcast

In this episode, Alexander Natz from EUCOPE chats about the European Health Data Space.

Cambridge, MA, USA - June 29, 2022: Moderna logo is seen at the entrance to its headquarters in Cambridge, Massachusetts. Moderna, Inc., is an American pharmaceutical and biotechnology company. | Image Credit: © Tada Images - stock.adobe.com

FDA Approves New Moderna COVID-19 Vaccine mNEXSPIKE

Patrick Lavery
June 2nd 2025
Article

A Phase III trial demonstrated mNEXSPIKE’s non-inferior efficacy compared with Moderna’s original COVID vaccine, Spikevax.

Teva Pharmaceuticals manufacturing site. Locally, Teva produces oral solid medicines and packaging. | Image Credit: © jetcityimage - stock.adobe.com

FDA Grants Fast Track Designation to Teva Celiac Disease Candidate

Patrick Lavery
May 30th 2025
Article

Teva’s investigational monoclonal antibody, TEV-53408, has been designed for use in adults with celiac disease, for which a strict and lifelong gluten-free diet is currently the only treatment.